share_log

醫思健康：內幕消息銷售額更新

EC HEALTHCARE: INSIDE INFORMATION SALES VOLUME UPDATE

Hong Kong Stock Exchange ·  May 6 06:24
Summary by Moomoo AI
醫思健康（EC Healthcare）公布截至2024年3月31日止年度的銷售額更新，顯示整體銷售額按年增長8%以上，達到不少於42億港元。該集團的香港及澳門美學醫療、美容及養生服務銷售額增長超過15%，而其他服務銷售額亦錄得不少於20%的增長。然而，中國內地相關服務的銷售額則出現不多於19%的下跌。董事會指出，這些初步未經審計的數據基於管理帳目評估，並未經核數師審閱或審核，提醒股東及潛在投資者在交易股份時需謹慎。公告由公司秘書蕭鎮邦於2024年5月6日發出。
醫思健康（EC Healthcare）公布截至2024年3月31日止年度的銷售額更新，顯示整體銷售額按年增長8%以上，達到不少於42億港元。該集團的香港及澳門美學醫療、美容及養生服務銷售額增長超過15%，而其他服務銷售額亦錄得不少於20%的增長。然而，中國內地相關服務的銷售額則出現不多於19%的下跌。董事會指出，這些初步未經審計的數據基於管理帳目評估，並未經核數師審閱或審核，提醒股東及潛在投資者在交易股份時需謹慎。公告由公司秘書蕭鎮邦於2024年5月6日發出。
EC Healthcare announced an update on sales for the year ended 31 March 2024, showing that overall sales grew by more than 8% year-on-year to at least HK$42 billion. The Group's sales of aesthetic medical, beauty and wellness services in Hong Kong and Macau grew by more than 15%, while sales of other services also recorded an increase of no less than 20%. However, sales of services related to the Mainland of China decreased by less than 19%. The Board notes that these preliminary unaudited data are based on management accounting assessments and have not been reviewed or audited by auditors, reminding shareholders and potential investors to exercise caution when trading shares. The announcement was made on 6 May 2024 by the Secretary of the Company, Mr Siu Zhenbang.
EC Healthcare announced an update on sales for the year ended 31 March 2024, showing that overall sales grew by more than 8% year-on-year to at least HK$42 billion. The Group's sales of aesthetic medical, beauty and wellness services in Hong Kong and Macau grew by more than 15%, while sales of other services also recorded an increase of no less than 20%. However, sales of services related to the Mainland of China decreased by less than 19%. The Board notes that these preliminary unaudited data are based on management accounting assessments and have not been reviewed or audited by auditors, reminding shareholders and potential investors to exercise caution when trading shares. The announcement was made on 6 May 2024 by the Secretary of the Company, Mr Siu Zhenbang.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more